Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Weintraub

Showing results (71-80 of 412) with videos related to

Pageof 42
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2025
Reply to: "Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example"Daniel Weintraub, Michael C Brumm, Ryan Kurth, et al.
Journal of the American Geriatrics Society|December 11, 2002
Second-generation issues in the management of depression in nursing homesDaniel Weintraub, Catherine J Datto, Joel E Streim, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 14, 2006
Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson diseaseDaniel Weintraub, Katherine A Oehlberg, Ira R Katz, et al.
Parkinsonism & Related Disorders|November 22, 2019
Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesSarah Horn, Hayley Richardson, Sharon X Xie, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 16, 2025
Author Response to Comment on "Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations"Ondrej Bezdicek, Roberta Biundo, Matej Skorvanek, et al.
Clinical Parkinsonism & Related Disorders|April 10, 2025
Impact of pimavanserin on prescribing practices in parkinson diseaseThanh Phuong Pham Nguyen, Vy Le, Daniel Weintraub, et al.
Neurology|August 17, 2014
Course of psychiatric symptoms and global cognition in early Parkinson diseasePatricia de la Riva, Kara Smith, Sharon X Xie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Impulse control disorders in Parkinson's disease: a national Swedish registry study on high-risk treatments and vulnerable patient groupsMirjam Wolfschlag, Gustav Cedergren Weber, Daniel Weintraub, et al.
Parkinsonism & Related Disorders|February 3, 2009
Involuntary emotional expression disorder (IEED) in Parkinson's diseaseLisa Phuong, Shalini Garg, John E Duda, et al.
The Lancet. Neurology|November 22, 2016
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyAnette Schrag, Uzma Faisal Siddiqui, Zacharias Anastasiou, et al.
Pageof 42

Showing results (71-80 of 412) with videos related to

Sort By:
Pageof 42
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2025
Reply to: "Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example"Daniel Weintraub, Michael C Brumm, Ryan Kurth, et al.
Journal of the American Geriatrics Society|December 11, 2002
Second-generation issues in the management of depression in nursing homesDaniel Weintraub, Catherine J Datto, Joel E Streim, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 14, 2006
Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson diseaseDaniel Weintraub, Katherine A Oehlberg, Ira R Katz, et al.
Parkinsonism & Related Disorders|November 22, 2019
Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesSarah Horn, Hayley Richardson, Sharon X Xie, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 16, 2025
Author Response to Comment on "Neuropsychological Tests of Memory, Visuospatial, and Language Function in Parkinson's Disease: Review, Critique, and Recommendations"Ondrej Bezdicek, Roberta Biundo, Matej Skorvanek, et al.
Clinical Parkinsonism & Related Disorders|April 10, 2025
Impact of pimavanserin on prescribing practices in parkinson diseaseThanh Phuong Pham Nguyen, Vy Le, Daniel Weintraub, et al.
Neurology|August 17, 2014
Course of psychiatric symptoms and global cognition in early Parkinson diseasePatricia de la Riva, Kara Smith, Sharon X Xie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Impulse control disorders in Parkinson's disease: a national Swedish registry study on high-risk treatments and vulnerable patient groupsMirjam Wolfschlag, Gustav Cedergren Weber, Daniel Weintraub, et al.
Parkinsonism & Related Disorders|February 3, 2009
Involuntary emotional expression disorder (IEED) in Parkinson's diseaseLisa Phuong, Shalini Garg, John E Duda, et al.
The Lancet. Neurology|November 22, 2016
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyAnette Schrag, Uzma Faisal Siddiqui, Zacharias Anastasiou, et al.
Pageof 42